Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Buprenorphine Transdermal Patch in Chinese Subjects with Chronic Pain
NCT03975010Phase 1Unknown
- Sponsor
- Mundipharma
- Start
- May 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of v1003 in chronic pain (3 arms), sponsored by Mundipharma. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve to the last measurable concentration and 1 more. Status: unknown.
02
Drugs
v1003
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT03975010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03975010.